Combination therapy for HIV-1 infection can reduce viremia to undetectable levels,
suggesting that prolonged treatment might eradicate the infection. However, one potential …

Combination antiretroviral therapy (ART) for HIV-1 infection reduces plasma virus levels to
below the limit of detection of clinical assays. However, even with prolonged suppression of …

Combination therapy for HIV-1 infection can reduce plasma virus to undetectable levels,
indicating that prolonged treatment might eradicate the infection. However, HIV-1 can persist …

Latent HIV-1 persists in resting memory CD4+ T cells, even in patients receiving highly
active antiretroviral therapy (HAART). It has been unclear how stable this latent reservoir is …

The success of combination antiretroviral therapy for HIV-1 infection has generated interest
in mechanisms by which the virus can persist in the body despite the presence of drugs that …

For some viruses, long-term persistence in the host depends on the establishment of
latency, a reversibly nonproductive state of infection. The alphaherpesviruses provide a …

Despite the remarkable success of highly active antiretroviral therapy (HAART) for the
treatment of HIV-1 infection, it now appears that the infection is intrinsically incurable with …

The discovery of a stable latent reservoir for HIV‐1 in resting memory CD4+ T cells provides
a mechanism for lifelong persistence of HIV‐1. The long‐lived latently infected cells persist …

A pool of latently infected CD4+ T cells is established within the first few weeks of HIV
infection. Because these memory T cells are inactive, the viral DNA integrated into their …

AIDS: Research has changed the approach to AIDS therapy, in part by suggesting that
eradication of the virus may be possible with highly active antiretroviral therapy (HAART) …